The biopharma world's manufacturing weekly

Endpoints Manufacturing

Manufacturing channel feed

Fu­ji­film con­tin­ues CD­MO ex­pan­sion, break­ing ground on $435M UK site

3 years ago

An­oth­er Cipla site lands a Form 483 over clean­ing is­sues and QC con­trols

3 years ago
Pharma
FDA+

EMA warns of short­ages of two Boehringer heart drugs due to a spike in de­mand

3 years ago
Pharma

Man­u­fac­tur­ing roundup: Lon­za fin­ish­es ex­pand­ing Visp site; CBM to pro­duce jCyte’s cell ther­a­py

3 years ago

Armed with cash, Bel­gian iP­SC play­er makes a play for Celyad’s cell ther­a­py man­u­fac­tur­ing site

3 years ago
Deals
Cell/Gene Tx

Ab­b­Vie ex­pands man­u­fac­tur­ing pres­ence in Ire­land with a €60M in­vest­ment

3 years ago
Financing

CD­MO makes an AI and drug dis­cov­ery play in lat­est, small-time ac­qui­si­tion

3 years ago
R&D

Catal­ent’s Covid-19 vac­cine man­u­fac­tur­ing site hit with Form 483 over for­eign ob­jects in vials and oth­er QC is­sues

3 years ago
Pharma
FDA+

Q&A: Re­silience boss Rahul Singhvi talks $2B US bio­man­u­fac­tur­ing ini­tia­tive and post Se­ries D deals

3 years ago
Pharma

A year af­ter em­bark­ing on a new HQ and man­u­fac­tur­ing site, Ab­Cellera starts sec­ond phase of its build­out

3 years ago
R&D

Ther­mo Fish­er con­tin­ues its ex­pan­sion dri­ve with open­ing of $160M Mass­a­chu­setts fa­cil­i­ty

3 years ago

Bavar­i­an Nordic inks an­oth­er ma­jor vac­cine con­tract with Cana­da

3 years ago
Pharma

Phlow looks to raise $50M as US aims to boost do­mes­tic man­u­fac­tur­ing

3 years ago

Mod­er­na CEO looks to Japan for build­ing new vac­cine man­u­fac­tur­ing site

3 years ago
Pharma
Coronavirus

J&J ex­pands in Ire­land with a $100M+ in­vest­ment for con­tact lens man­u­fac­tur­ing site

3 years ago

Man­u­fac­tur­ing roundup: WuXi STA un­veils new fa­cil­i­ty; Pur­due Uni­ver­si­ty nets $3M grant for ze­ro-waste phar­ma man­u­fac­tur­ing

3 years ago

Fu­ji­film Diosynth breaks ground on a $1.6B ex­pan­sion project in Den­mark

3 years ago
Cell/Gene Tx

FDA un­veils list of al­ter­na­tive ways to com­ply with cGMP re­quire­ments for com­bo prod­ucts

3 years ago
Pharma
FDA+

US gov­ern­ment pledges $2B for new ini­tia­tive on bio­man­u­fac­tur­ing

3 years ago
Pharma

Take­da’s man­u­fac­tur­ing site in Bel­gium gets a €300M boost for plas­ma ther­a­py pro­duc­tion

3 years ago
Financing

Form 483 un­masks man­u­fac­tur­ing is­sues at Alvotech be­fore its CRL, and one for Au­robindo too

3 years ago
Pharma
FDA+

Forge Bi­o­log­ics con­tin­ues its hot streak with $90M round to boost gene ther­a­py man­u­fac­tur­ing ser­vices

3 years ago
Financing
Outsourcing

In the mid­dle of an R&D shake­up, No­var­tis makes a $300M in­vest­ment in ear­ly-stage bi­o­log­ics re­search tech

3 years ago
Pharma

Man­u­fac­tur­ers sound off on FDA drug re­port­ing guid­ance, point­ing to chal­lenges and rec­om­men­da­tions

3 years ago
Pharma
FDA+
First page Previous page 43444546474849 Next page Last page
A service from the Financial Times